New Data Show That Subcutaneous Injection of an Investigational Formulation of ORENCIA® (abatacept) Provided Similar Improvements in Disease Activity Compared to Intravenous Administration of ORENCIA

close

Get every new post delivered right to your inbox.

Original Source